SiteServicesPhonebook

Events

Evidence Needed to Support the Clinical Utility of Molecular Diagnostics

View the event details below.

Description: Many decisions for cancer patient management depend on information derived from clinical laboratory tests in addition to that derived from the clinical evaluation of these patients. At this workshop, participants will discuss and debate the definition of clinical utility for oncologic treatment, the evidence needed to demonstrate clinical utility for a molecular diagnostic, how that evidence should be obtained, and how NCI can best assist in the demonstration of clinical utility in the context of clinical trials. NCI will use this workshop to inform decisions about its role in this endeavor. The workshop format will be primarily interactive, with most of the time devoted to small focused breakout discussion groups.
Event Type: Conference
Start time: 1/10/2013 at 8:00 AM All day event
End time: 1/11/2013 at 12:00 PM
Website: [N/A]
VideoCast: [N/A]

The campus and location are listed below.

The series is listed below.

If applicable, event speakers are listed below.

Steven Gutman

Affiliation: [N/A]
Description: [N/A]
Phone: [N/A], E-mail: [N/A]

Daniel Hayes

Affiliation: [N/A]
Description: [N/A]
Phone: [N/A], E-mail: [N/A]

Walter Koch

Affiliation: Roche
Description: [N/A]
Phone: [N/A], E-mail: [N/A]

James Rae

Affiliation: University of Michigan
Description: [N/A]
Phone: [N/A], E-mail: [N/A]

Steven Shak

Affiliation: Genome Health
Description: [N/A]
Phone: [N/A], E-mail: [N/A]

If applicable, event contacts are listed below.

Julia Lam

E-mail: lamj@mail.nih.gov